Showing results (11-20 of 151) with videos related to
Sort By:
Pageof 16
Kidney International|April 10, 2018
Drug repurposing in kidney diseaseUsha Panchapakesan, Carol PollockExpert Review of Clinical Pharmacology|April 11, 2014
Empagliflozin for the treatment of Type 2 diabetesMuralikrishna Gangadharan Komala, Amanda MatherSurgery|November 11, 2018
Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimeticsWillemijn Y van der Plas, Anton F Engelsman, Marille Umakanthan, et al.Advances in Chronic Kidney Disease|December 19, 2021
Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without DiabetesCarol Pollock, Brendon L NeuenClinical and Experimental Pharmacology & Physiology|December 16, 2010
Renal epidermal growth factor receptor: its role in sodium and water homeostasis in diabetic nephropathyUsha Panchapakesan, Carol Pollock, Sonia SaadNephrology (Carlton, Vic.)|May 16, 2009
Review article: importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptakeUsha Panchapakesan, Carol Pollock, Sonia SaadInternational Journal of Nanomedicine|August 29, 2007
Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator)Usha Panchapakesan, Siska Sumual, Carol PollockClinical Science (London, England : 1979)|February 5, 2014
Role of Toll-like receptors in diabetic nephropathyHarshini Mudaliar, Carol Pollock, Usha PanchapakesanThe Australasian Medical Journal|November 8, 2014
SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetesRobert G Moses, Stephen Colagiuri, Carol PollockInternational Journal of Molecular Sciences|July 2, 2021
Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal InjuryLucy Birtwistle, Xin-Ming Chen, Carol PollockPageof 16